Bill > LB168

This bill introduces the 340B Contract Pharmacy Protection Act, which regulates how drug manufacturers interact with 340B entities (healthcare providers like hospitals and clinics that serve vulnerable populations and can purchase drugs at reduced prices under a federal program). The bill defines key terms such as 340B drugs and entities, and establishes two primary protections: first, manufacturers cannot deny or restrict a 340B entity's ability to acquire or receive 340B drugs unless prohibited by federal law, and second, manufacturers cannot require 340B entities to submit additional data as a condition of drug acquisition unless mandated by federal law. The bill allows the Attorney General or county attorneys to take legal action to prevent violations of these provisions, and includes a clause ensuring that the act will not conflict with existing federal or state laws. The legislation also contains standard severability and emergency effect provisions, meaning it will take effect immediately upon passage and that if any part of the act is found invalid, the rest of the act remains in force.

Business and Industry

https://nebraskalegislature.gov/bills/view_bill.php?DocumentID=59194